New Build Report: Pharmaceutical-Biotech Sector to Open 113 New Facilities in 2015 with $4.7 Billion in Capital Investment Potential

SUGAR LAND--January 23, 2015--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--Scattered throughout North America are 113 reported new facility builds in the Pharmaceutical-Biotech Industry that are scheduled to open their doors by the end of the year, according to Industrial Info's Pharmaceutical-Biotech Online Database. The sites potentially represent a total capital investment of $4.7 billion, which translates to a per-site average of about $41.5 million.

Within this article: Details on key projects from major companies, such as Colgate-Palmolive (NYSE:CL), Thermo Fisher Scientific Incorporated (NYSE:TMO) and Church & Dwight Incorporated (NYSE:CHD).